- Report
- February 2024
- 125 Pages
Global
From €4199EUR$4,250USD£3,495GBP
- Report
- February 2024
- 120 Pages
Global
From €4693EUR$4,750USD£3,906GBP
- Report
- February 2024
- 110 Pages
Global
From €4693EUR$4,750USD£3,906GBP
- Clinical Trials
- April 2024
- 115 Pages
Global
From €1383EUR$1,400USD£1,151GBP
€1976EUR$2,000USD£1,645GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €865EUR$875USD£720GBP
€1235EUR$1,250USD£1,028GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €865EUR$875USD£720GBP
€1235EUR$1,250USD£1,028GBP
- Report
- July 2024
- 100 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- July 2024
- 150 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- July 2024
- 150 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- July 2024
- 150 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- July 2024
- 100 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- July 2024
- 100 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- July 2024
- 100 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Clinical Trials
- July 2024
- 60 Pages
Global
From €1037EUR$1,050USD£864GBP
€1482EUR$1,500USD£1,234GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Clinical Trials
- June 2024
- 60 Pages
Global
From €1037EUR$1,050USD£864GBP
€1482EUR$1,500USD£1,234GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more